Vor Biopharma is a biopharmaceutical company developing novel therapies for treating cancer. It develops a health and safety commission technology platform to address the limitations of the immunotherapies, including antibody-drug conjugates, bispecific antibodies, and chimeric antigen receptor T cells. The company engineers hematopoietic stem cells (eHSCs) to protect the blood and bone marrow from the toxic effects of antigen-targeted therapies, protecting healthy cells from depletion.
|HQ||Cambridge, MA, US||Map|
Net income (Q1, 2021)
EBIT (Q1, 2021)
Market capitalization (21-Oct-2021)
Closing stock price (21-Oct-2021)
|Company Name||Date||Deal Size|
|Vor Biopharma Securities Corporation|
When was Vor Biopharma founded?
Vor Biopharma was founded in 2016.
Who are Vor Biopharma key executives?
Vor Biopharma's key executives are Robert Ang, Sadik Kassim and Tirtha Chakraborty.
How many employees does Vor Biopharma have?
Vor Biopharma has 76 employees.
Who are Vor Biopharma competitors?
Competitors of Vor Biopharma include TScan Therapeutics, Elicio Therapeutics and Shoreline Biosciences.
Where is Vor Biopharma headquarters?
Vor Biopharma headquarters is located at 215 First St Suite 430, Cambridge.
Where are Vor Biopharma offices?
Vor Biopharma has an office in Cambridge.
How many offices does Vor Biopharma have?
Vor Biopharma has 1 office.
Receive alerts for 300+ data fields across thousands of companies